The relationship of residual insulin positivity in chronic Type I (insulin-dependent) diabetes and atrophy of the exocrine pancreas to duration of diabetes, age at onset and microangiopathy was studied in 26 patients (disease duration 2 to 54 years, mean 26 years). Islets containing insulin cells were found in 13/26 pancreata. In 5/13 pancreata insulin positive cells were detected in only one lobule, while in 8/13 insulin positivity was multifocal. All patients with diabetes duration less than 11 years had residual insulin cells; whereas, the rate of insulin positivity was near 40% with diabetes duration of more than 11 and 21 years, respectively. Survival of insulin cells was not clearly related to age at onset. HLA-DR expression on insulin cells was seen in one case. lnsulitis was lacking. Pancreatic volume determined in 18 patients ranged from 14-110ml (age adjusted mean 56.3 ml) and was significantly less than that of control subjects (age adjusted, mean 89.9 ml, p < 0.0001). Computerized morphometry of the exocrine pancreas revealed severe acinat atrophy due to a reduction in size of acinar cells. Acinar atrophy correlated neither with the degree of insulin positivity, disease duration nor severity of microangiopathy. The findings suggest that in about 40% of patients with Type 1 diabetes a small population of insulin cells may escape autoimmune destruction, irrespective of disease duration or age at onset. Though exocrine atrophy and insulin deficiency are associated, the variable extent of pancreatic atrophy could not to be related to such factors as amount of surviving insulin cells, duration of diabetes or microangiopathy.
Loss of insulin cells characterises the islet lesions in patients with Type 1 (insulin-dependent) diabetes mellitus [1] [2] [3] [4] . This loss, however, need not to be complete, since B cells, though severely reduced, have been demonstrated even in patients with a diabetes duration up to 37 years [1, 3] , The mechanisms which may protect some insulin cells from destruction by the autoimmune process underlying Type I diabetes are largely unkrlown.
Another finding that characterises the pancreas in chronic Type 1 diabetes is a reduction in weight and volume [3, [5] [6] [7] [8] . The pancreatic atrophy is attributed to the lacking trophic effect of insulin on the acinar cells [2, 3, [9] [10] [11] [12] [13] . The extent of the exocrine atrophy, however, appears to vary considerably from patient to patient and has not yet been related to the remaining insulin positivity in the pancreas, to diabetes duration or to the degree of microangiopathy. * Presented in part at the 22 nd EASD meeting in Rome, 1986 ** Present address: Department of Pathology, Free University of Brussels, Belgium
The aim of the present study was to investigate the degree and distribution of residual insulin positivity in the pancreas of patients with long-standing Type 1 diabetes by immunocytochemistry and to determine the degree of pancreatic atrophy by morphometry. The results from these two determinations were then related to diabetes duration, age at onset and extent of microangiopathy to see whether these parameters have any impact on the survival of insulin cells and a decrease of pancreatic volume.
Subjects and methods
In 26 patients (14 males, 12 females) with Type 1 diabetes of long duration (2-54 years, mean 26 years), the pancreas and the kidneys were studied at autopsy. Autopsies were performed at varying intervals post mortem, with a range from 14 to 26 h. Clinical data regarding age at onset and duration of diabetes were collected. Death was related to complications of diabetes, i. e. nepbropathy, myocardial infarction and coma.
The pancreas was carefully dissected and in 18 cases its volume was determined by Archimedes' principle. The same was done in 45 nondiabetic control subjects who died of diseases unrelated to the pancreas. In 19 of these 45 patients, the pancreas was used for morphometric evaluation of the exocrine compartment. The interval between death and examination in the control subjects averaged 24 h. The pancreas was cut into slices and fixed in Bouin's solution. Material was obtained from eight regions coded by anatomic location according to the protocol proposed by Malaisse-Lagae et al. [14] . From each block, serial sections (3 ~tm) were cut after routine paraffin processing. The first three sections were stained with H&E, periodic acid Schiff (PAS) and Masson-Goldner. Immunocytochemistry was performed on the subsequent deparaffinised sections, as described elsewhere [15] . A monoclonal antibody was used against insulin (Biogenex via Camon, Wiesbaden, FRG) and polyclonal antibodies against glucagon (INC, International Nuclear Corporation, Stillwater, Minn, USA), somatostatin (INC) and human pancreatic polypeptide (HPP, gift of Dr. R. E. Chance, Indianapolis, Ind, USA). The primary dilutions were 1:20, 1:5000, 1:5000 and 1:10000 respectively. In addition to the hormonal antibodies, we used two antibodies against the non-polymorphous region of the HLA-DR antigen, EPl13 (gift of Dr. H. G. Thiele, Hamburg, FRG [16[) and TAL-B 5 (gift of C. Dixon, London, UK [17] ) known to react on paraffin embedded tissue at dilutions of I : 10 000 and 1 : 20 respectively.
The sections were evaluated regarding insulitis, insulin cell content of the islets and localisation and frequency of insulin positive islets in the pancreas. The presence of insulin positive islets in one lobule was graded 1 +, while insulin positive islets in more than one lobule were graded 2+. The islets in control subjects were graded 3 +. In five pancreata (two with t + insulin positivity, three with 2 + insulin positivity) four to five randomly selected insulin positive islets were evaluated by point counting to determine the percentage of total islet surface area occupied by each of the four islet cell types. The percentages were then averaged and a group mean was calculated.
To evaluate the volume density of the acinar cell compartment in the patients with diabetes and 19 normogiycaemic normal weight control subjects, the areas occupied by the nuclei and the cytoplasm of the acinar ceils were separately measured on a Masson-Goldner stained cross-sectional slide of the pancreas. The morphometric equipment included a standard light microscope (Zeiss, Oberkochen, FRG) with a semi-automatic image analyser (Kontron, Mtinchen, FRG) [18] . The image of the pancreatic parenchyma, as seen in the microscope at a total magnification of x 63, appeared on a color monitor and was then transformed by color-tone and grey-tone level discrimination into a black and white picture. Four different areas from the body and tail of the pancreas were arbitrarily chosen for evaluation. From the two parameters measured, the nucleus/cell (cytoplasm plus nucleus)-ratio (N/C ratio) was calculated. In addition, the number of nuclei per 0.5 mm 2 (monitor screen area at • 63 magnification) was determined.
To estimate the degree of microvascular changes, thickening of the basement membrane of capillaries and arterioles, as visualized by PAS staining, was recorded separately in the pancreas and the kidneys of each patient by two reviewers independently. In the pancreas, a moderate basement membrane thickening was graded 1 +, while severe changes were recorded 2 +. In the kidneys, the microvascular alterations, i.e. glomerulosclerosis (GS), were graded according to the following scheme [19] : slightly diffuse GS (1); moderately diffuse and <50% nodular GS (2); severely diffuse and moderate GS with>10% hyalinosis (3); and severe GS with over 50% hyalinosis (4) . Comparison of the graded vascular changes of the pancreas and kidney revealed close correlation between 1 + pancreatic microangiopathy and GS (1) and (2), and 2 + microangiopathy and GS (3) and (4) (r = 0.73).
Statistical analysis
The insulin positivity scores, the pancreatic volumes and the volume densities of the acinar cells were correlated with diabetes duration, age at onset and microvascular changes. The statistical tests to analyse these data included analysis of variance and forward stepwise multiple linear regression [20] . Differences between groups were considered to be statistically significant when a corresponding test (Kruskal-Wallis and Mann-Whitney, respectively) showed a twosided level of significance of p < 0.05 [21] .
Results
The 26 diabetic patients studied ranged in age from 12-76 years (mean 48 years). The age at onset varied from 3-65 years (mean 22 years) and the duration of diabetes from 2-54years (mean 26 years) ( Table 1) . One patient who developed insulin-dependent diabetes at the age of 65 also suffered from hypothyroidism. In the 19 control subjects whose exocrine pancreas was evaluated by morphometry, the age ranged from 6-67 years (mean 40 years).
In 13 diabetic patients, the pancreata contained islets with insulin-producing cells. In 5/13 pancreata the insulin positive islets were restricted to one lobule of the pancreas (1 +), whereas insulin-positive islets in more than one lobule (2+) were found in 8/13 pancreata. All 1 + pancreata had a greater loss of B cells than the 2 + pancreata. Insulin positive islets showed no preferred localisation in the pancreas. In the PPlobe insulin cells were always absent. The vast majority of insulin positive islets were strongly depleted of B cells. In five pancreata where the percentage of each endocrine cell type was determined, the proportion of insulin cells ranged from 3 to 28% (mean 14%), while the mean percentage of glucagon, somatostatin and PP cells was 63%, 17% and 6% respectively. Insulitis could not be detected, even after serial sectioning of blocks with insulin positivity, which was done in two cases. Coexpression of insulin and HLA-DR was observed on 3 ~tm serial sections in one case of a 13-year-old boy with diabetes duration of 4 years. In this case, 4 blocks showed insulin-positive cells but HLA-DR expression on B cells was only present in a few islets from the head region. HLA-DR was consistently found to be expressed on endothelial cells. Patchy interstitial lymphocytic infiltration of the exocrine pancreas was observed in 3/26 patients.
Incidence and degree of insulin positivity did not correlate significantly with a diabetes duration of less or more than 21 years. Insulin positive cells were found in all 3 patients with a diabetes duration of less than 11 years (Fig.l) . Between 11 and 21 years diabetes duration, the positivity rate was 37%, and over 21 years 46%. No significant relationship was found between the patients' age at onset of diabetes and residual insulin positivity.
In 18 patients, the pancreatic volume ranged from 14-110 ml. Compared with the normal mean pancreatic volumes of 600 glands as reported by RSssle [22] and established in our own series of 45 age and sex matched control subjects, the values found in the diabetic patients were markedly reduced (Fig. 1) . To demonstrate the finding more clearly, the volumes from the individual cases were age adjusted to the values found at the age of 35 years (peak volume) ( Table 2) . Significant differences were neither found between the insulin positive and negative diabetic patients nor between patients of less or more than 21 years diabetes duration. Even in those with a diabetes duration less than 11 years the pancreata were significantly smaller (p < 0.0001) (Fig. 2) .
In all regions of the pancreas, including the PPlobe [23] , the acinar cells appeared to be smaller than those of the controls (Fig.3) . The perilobular spaces, and to some degree also the interacinar spaces, were enlarged and contained loosely arranged connective tissue.
Pancreatic acinar cells surrounding islets still containing insulin cells generally showed the same degree of atrophy as those embracing insulin negative islets.
Quantitatively, the parenchymal volume (i.e. volume density • pancreatic volume in ml) was significantly less in the diabetic patients with lowest values in the insulin positive categories ( Table 2) .
The mean values of the N/C ratio were markedly decreased in the diabetic patients but significance in the differences to the control subjects was only reached in the insulin positive cases (Table 2 ). No differences were found between the insulin positive and insulin negative cases. The number of nuclei/0.5 mm 2 was decreased in all diabetic groups but was lowest in the insulin positive cases when compared with controls (Table 2) .
With regard to microangiopathy in the pancreas and the kidney, 3/26 had zero, 11 had 1 + and 12 had 2 + microvascular changes. There was no correlation between micr0angiopathy and the duration of diabetes or the degree of insulin positivity.
Discussion
The results of our study confirm and extend earlier observations showing that insulin cells, though severely reduced in number, may be present in the pancreata of patients with long standing Type 1 diabetes even decades after disease onset [1] [2] . Small clusters of islets containing a few insulin cells were found in 50% (13/26) of our patients. This percentage of insulin positive patients, though presumably somewhat underestimated because of incompleteness of our screening technique, is still greater than that found in studies on C-peptide secretion in chronic Type 1 diabetes. Measurable C-peptide levels were found in 15% to 24% of patients with a diabetes duration of more than 10 and 18 years respectively [24] [25] . The most likely explanation for this discrepancy is that only those patients with multifocal residual insulin positivity are capable of secreting sufficient amounts of C-peptide to be measured. Thus, if we consider only our patients with disease duration over 11 years and multifocal insulin positivity, the percentage of positive cases (about 30%) compares better with those of C-peptide secreting patients with Type 1 diabetes. It is clear that these correlations are far from satisfactory, since our method of quantifying the remaining insulin cells allows only a rough estimation of their mass. However, considering the non-random distribution of the surviving insulin cells in the pancreas, we refrained from calculating the insulin cell volume by sophisticated stereologic techniques because such calculations would lead to irrelevant results.
Presence or absence of insulin cells in chronic Type 1 diabetes could not be related to the age at onset, but showed a certain dependency on diabetes duration. In the study of Gepts and DeMey [1] , B cells were found in 50% of patients with an insulin-dependent diabetes of less than 11 years duration and in 18% of those with a longer duration. From these data it appears that the longer the diabetes lasts the smaller the chance for survival of B cells. This view is also supported by our study, since all patients with a diabetes duration of less than 11 years still had insulin ceils in their pancreata. However, when we extended the diabetes duration beyond the 11 year level and compared patients whose diabetes had lasted 10 to 21 or more than 21 years, a relationship between disease duration and survival of insulin cells no longer existed. Thus, it may be speculated that probably most of the patients whose pancreata still contain insulin cells after a diabetes duration of 10 to 20 years, will retain these insulin cells for the rest of their lives.
Since insulin positive islets had not totally disappeared from cases with extremely long disease duration, it seems that these insulin cells had escaped destruction by immune mechanisms thought to be active in Type I diabetes [26] . One of the factors under recent investigation is an aberrant HLA-DR expression on B cells which is thought to be involved in the induction of the autoimmune process and possibly precedes insulitis [26] [27] [28] . In our series of 13 insulin positive patients, we found no insulitis and in only one patient coexpression of insulin and HLA-DR in very few islet cells. There are two hypotheses which might explain the phenomenon of long surviving insulin cells. Either these residual insulin cells had never expressed HLA-DR and have to be considered as remnants of an originally HLA-DR free B-cell population or they represent regenerated B cells which no longer express HLA-DR [26] . Though there is as yet no ready explanation for the longtime survival of insulin cells, this observation is of interest with respect to the theoretical possibility to reactivate the growth of this resting pool of B cells.
Patients with chronic Type 1 diabetes display a considerable reduction in weight and volume of the pancreas [1, [6] [7] [8] . These findings are confirmed by our study, since all but one pancreas of our series showed volume values far below those found in nondiabetic subjects [22] . This volume reduction of the pancreas was found to be due to a severe atrophy of all acinar cells (including those of the PP-lobe), since the reduction in parenchymal volume was paralleled by a decline in cell numbers per given area (expressed as nuclei per 0.5 mm2). The fact that in the diabetic pancreata the acinar cells, despite their smaller size, did not increase in number per area can be explained by the development of a diffuse interstitial fibrosis conspicuously enlarging the interstitial spaces. A comparison of the ratio of the nuclear area to the acinar cell area (N/C ratio) of control subjects with that in diabetic patients showed that the decrease in cell size was particularly due to a decline of the nuclear volume.
Lack of endogenous insulin has been suggested as causing the atrophy of the pancreas in chronic Type 1 diabetes [12, [29] [30] [31] , as insulin has been shown to promote growth and protein synthesis of the acinar cells [11] [12] [13] 30 ]. This conclusion is substantiated by clinical studies on the exocrine secretory capacity of the pancreas in chronic Type I diabetes demonstrating decreased secretion of enzymes [32] [33] [34] [35] [36] . Frier et al. found that the preservation of pancreatic function correlates with the duration of diabetes [32] and the persistence of B-cell secretory activity measured by C-peptide levels [33] . Domschke et al. [34] and Lankisch et al. [35] , however, were not able to confirm these correlations. Our results are more in keeping with the latter observations, since we failed to demonstrate clear relationships between the extent of exocrine atrophy and residual insulin positivity, the age at onset or duration of diabetes. This suggests that insulin secretion from a few remaining insulin cells is not sufficient to exert a significant trophic effect on the acinar cells.
As a further factor which may influence pancreatic exocrine atrophy, microangiopathy has to be discussed. In our study, however, microangiopathy, as judged by the degree of renal glomerulosclerosis and pancreatic arteriosclerosis, was found to be unrelated to the extent of exocrine atrophy and thus seems to play no significant role in the pathogenesis of pancreatic atrophy in chronic Type 1 diabetes.
In conclusion, we demonstrated persisting residual insulin positivity in about 40% of patients with Type 1 diabetes after a disease duration of more than 11 years. Exocrine atrophy, though closely linked to a state of insulin deficiency, appeared not to be further influenced by such variables as surviving insulin cells, diabetes duration or microangiopathy.
